Loading company…
Outpost Bio uses machine learning and microbiology to study microbial interactions that affect human health.
Founded in 2025 and based in Boston, Outpost Bio develops computational models and datasets to study microbial interactions and their effects on human health. Its work combines machine learning with laboratory science for microbiome research and precision medicine. In March 2026, it raised USD 3.5 mn in pre-seed funding co-led by Merantix Capital and Seedcamp, with participation from OpenSeed VC and Defined Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in